Vimal Mehta

1.1k total citations
62 papers, 566 citations indexed

About

Vimal Mehta is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vimal Mehta has authored 62 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 27 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vimal Mehta's work include Cardiovascular Function and Risk Factors (14 papers), Cardiac Valve Diseases and Treatments (13 papers) and Lipoproteins and Cardiovascular Health (8 papers). Vimal Mehta is often cited by papers focused on Cardiovascular Function and Risk Factors (14 papers), Cardiac Valve Diseases and Treatments (13 papers) and Lipoproteins and Cardiovascular Health (8 papers). Vimal Mehta collaborates with scholars based in India, United States and South Africa. Vimal Mehta's co-authors include Ramesh Arora, Partho P. Sengupta, Vijay Trehan, Bijoy K. Khandheria, Jagdish C. Mohan, Saibal Mukhopadhyay, Jamal Yusuf, Natesa G. Pandian, Rishi Sukhija and Sanjay Tyagi and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and The American Journal of Cardiology.

In The Last Decade

Vimal Mehta

55 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vimal Mehta India 15 357 202 144 116 94 62 566
Muhammet Raşit Sayın Türkiye 11 246 0.7× 117 0.6× 93 0.6× 77 0.7× 66 0.7× 74 473
Jamal Yusuf India 12 418 1.2× 152 0.8× 173 1.2× 265 2.3× 78 0.8× 93 608
Alain Grentzinger France 12 400 1.1× 179 0.9× 118 0.8× 126 1.1× 245 2.6× 32 655
Yong-Jin Kim South Korea 13 497 1.4× 131 0.6× 166 1.2× 127 1.1× 155 1.6× 49 655
Monodeep Biswas United States 12 276 0.8× 98 0.5× 112 0.8× 48 0.4× 113 1.2× 28 453
T. Subramaniam India 14 279 0.8× 82 0.4× 160 1.1× 134 1.2× 76 0.8× 21 645
Joalbo M. Andrade Brazil 11 406 1.1× 143 0.7× 159 1.1× 64 0.6× 212 2.3× 14 604
Ilgın Karaca Türkiye 14 297 0.8× 235 1.2× 72 0.5× 63 0.5× 51 0.5× 44 590
Paolo Ferrazzi Italy 13 432 1.2× 298 1.5× 150 1.0× 212 1.8× 40 0.4× 26 731
Nagaraja Moorthy India 11 155 0.4× 134 0.7× 72 0.5× 87 0.8× 33 0.4× 80 364

Countries citing papers authored by Vimal Mehta

Since Specialization
Citations

This map shows the geographic impact of Vimal Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vimal Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vimal Mehta more than expected).

Fields of papers citing papers by Vimal Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vimal Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vimal Mehta. The network helps show where Vimal Mehta may publish in the future.

Co-authorship network of co-authors of Vimal Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Vimal Mehta. A scholar is included among the top collaborators of Vimal Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vimal Mehta. Vimal Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raal, Frederick J., Vimal Mehta, Meral Kayıkçıoğlu, et al.. (2025). Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial. The Lancet Diabetes & Endocrinology. 13(3). 178–187. 6 indexed citations
2.
3.
Yusuf, Jamal, et al.. (2023). R wave peak time and no reflow following primary percutaneous coronary intervention: Immediate and short-term outcomes. Journal of Electrocardiology. 79. 66–74. 2 indexed citations
4.
Dabla, Pradeep Kumar, et al.. (2023). Type 2 diabetes mellitus and coronary artery stenosis: a risk pattern association study. SHILAP Revista de lepidopterología. 336–342. 2 indexed citations
5.
Mehta, Vimal, Jamal Yusuf, Saibal Mukhopadhyay, et al.. (2022). Gender differences in genotypic distribution of endothelin-1 gene and endothelin receptor A gene in pulmonary hypertension associated with rheumatic mitral valve disease. Indian Heart Journal. 74(5). 375–381. 1 indexed citations
6.
Bansal, Sandeep, Andrea Ruzza, Vimal Mehta, et al.. (2021). Evolocumab in patients with homozygous familial hypercholesterolemia in India. Journal of clinical lipidology. 15(6). 814–821. 16 indexed citations
7.
Mehta, Vimal, Jamal Yusuf, Mohit Gupta, et al.. (2021). Left atrial function by two-dimensional speckle tracking echocardiography in patients with severe rheumatic mitral stenosis and pulmonary hypertension. Indian Heart Journal. 74(1). 63–65. 7 indexed citations
8.
9.
10.
Sawhney, J.P.S., Ajit Mullasari, Dhiman Kahali, et al.. (2019). Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study. Indian Heart Journal. 71(1). 25–31. 6 indexed citations
11.
Mukhopadhyay, Saibal, et al.. (2016). Circulating level of regulatory T cells in rheumatic heart disease: An observational study. Indian Heart Journal. 68(3). 342–348. 18 indexed citations
12.
Yusuf, Jamal, Mayank Goyal, Saibal Mukhopadhyay, et al.. (2015). Effect of heart rate control on coagulation status in patients of rheumatic mitral stenosis with atrial fibrillation – A pilot study. Indian Heart Journal. 67. S40–S45. 11 indexed citations
13.
Yusuf, Jamal, Saibal Mukhopadhyay, Abhishek Goyal, et al.. (2014). Relook at lipoprotein (A): Independent risk factor of coronary artery disease in North Indian population. Indian Heart Journal. 66(3). 272–279. 13 indexed citations
14.
Mehta, Vimal, Faizan Ahmed, Amit Banerjee, et al.. (2013). Correlation of Early Functional Capacity With Biventricular Function and Residual Pulmonary Artery Hypertension Following Mitral Valve Replacement Surgery. Journal of Cardiopulmonary Rehabilitation and Prevention. 33(4). 244–248. 4 indexed citations
15.
Yusuf, Jamal, Devendra K. Agrawal, Saibal Mukhopadhyay, et al.. (2013). Fragmented narrow QRS complex: Predictor of left ventricular dyssynchrony in non-ischemic dilated cardiomyopathy. Indian Heart Journal. 65(2). 172–179. 14 indexed citations
16.
Yusuf, Jamal, et al.. (2010). Pseudoaneurysm of the Left Ventricle in a Young Asymptomatic Female. Echocardiography. 27(3). 329–331. 3 indexed citations
17.
Trehan, Vijay, Saibal Mukhopadhyay, Jamal Yusuf, et al.. (2005). Mitral Valvuloplasty by Inoue Balloon Under Transthoracic Echocardiographic Guidance. Journal of the American Society of Echocardiography. 18(9). 964–969. 10 indexed citations
18.
Sengupta, Partho P., et al.. (2005). Doppler tissue imaging improves assessment of abnormal interventricular septal and posterior wall motion in constrictive pericarditis. Journal of the American Society of Echocardiography. 18(3). 226–230. 20 indexed citations
19.
Arora, Ramesh, Partho P. Sengupta, Ashish Thakur, Vimal Mehta, & Vijay Trehan. (2003). Device Closure of Patent Ductus Arteriosus. Journal of Interventional Cardiology. 16(5). 385–391. 11 indexed citations
20.
Mehta, Vimal, et al.. (1993). Effect of pyrazinamide on rifampicin kinetics in patients with tuberculosis. Tubercle and Lung Disease. 74(2). 87–90. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammet Raşit Sayın Breakdown of academic impact, for papers by Jamal Yusuf Breakdown of academic impact, for papers by Alain Grentzinger Breakdown of academic impact, for papers by Yong-Jin Kim Breakdown of academic impact, for papers by Monodeep Biswas Breakdown of academic impact, for papers by T. Subramaniam Breakdown of academic impact, for papers by Joalbo M. Andrade Breakdown of academic impact, for papers by Ilgın Karaca Breakdown of academic impact, for papers by Paolo Ferrazzi Breakdown of academic impact, for papers by Nagaraja Moorthy
Rankless by CCL
2026